FDA Approves VELCADE(R) (Bortezomib) For Injection For Aggressive Form Of Non-Hodgkin's Lymphoma

... Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval of VELCADE for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. [click link for full article] ...